Wells Fargo
DGX icon

Wells Fargo’s Quest Diagnostics DGX Stock Holding History

Wells Fargo’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19,600
Closed -$3.74M – 7169
2025
Q3 		$3.74M Buy
+19,600
New +$3.48M ﹤0.01% 2813
2024
Q3 		– Sell
-35,000
Closed -$4.79M – 6950
2024
Q2 		$4.79M Buy
+35,000
New +$4.79M ﹤0.01% 2278

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Wells Fargo's DGX Position: Q1 2026 in Review

Wells Fargo reduced its Quest Diagnostics (DGX) stake by 0.36% in Q1 2026, selling an estimated $1.23M and leaving 1,762,769 shares worth $345M. The position accounts for 0.07% of the portfolio, ranked #259.

Wells Fargo first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Wells Fargo held 1,762,769 shares of Quest Diagnostics worth $345M as of Q1 2026.
  • Wells Fargo sold 6,324 Quest Diagnostics shares in Q1 2026, an estimated $1.23M.
  • Quest Diagnostics made up 0.07% of Wells Fargo's portfolio in Q1 2026, its #259 holding.
  • Wells Fargo first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.